Success Metrics

Active Trials
3(43%)

Phase Distribution

Ph phase_3
3
43%
Ph phase_2
4
57%

Phase Distribution

0

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
4(57.1%)
Phase 3Large-scale testing
3(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

7

all time

Status Distribution
Active(4)
Other(3)

Detailed Status

unknown3
Active, not recruiting2
Recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
3
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 24 (57.1%)
Phase 33 (42.9%)

Trials by Status

active_not_recruiting229%
recruiting114%
not_yet_recruiting114%
unknown343%

Recent Activity

3 active trials
Showing 5 of 7
not_yet_recruitingphase_3

A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis.

NCT07199257
recruitingphase_3

A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis

NCT07154342
active_not_recruitingphase_2

A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).

NCT06315426
unknownphase_2

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma

NCT06642961
active_not_recruitingphase_2

The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps

NCT05873803
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT07199257Phase 3

A Study of GR1802 Injection in Patients With Seasonal Allergic Rhinitis.

Not Yet Recruiting
NCT07154342Phase 3

A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis

Recruiting
NCT06315426Phase 2

A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).

Active Not Recruiting
NCT06642961Phase 2

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma

Unknown
NCT05873803Phase 2

The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps

Active Not Recruiting
NCT06216392Phase 3

Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis

Unknown
NCT06015243Phase 2

The Study of Long-term Outcomes of GR1802 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Unknown

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7